Drupal.behaviors.print = function(context) {window.print();window.close();}>
FDA Approves Ventana Breast Cancer Test on Additional Platform
March 01, 2012
FDA Approves Ventana Breast Cancer Test on Additional Platform
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
FDA Approves HER2 Test for Breast Cancer
June 14, 2011 / GenomeWeb Daily News
FDA Approves Dako Assays as CDx for Genentech Breast Cancer Drug
March 5, 2013 / GenomeWeb Daily News
FDA Approves Dako's HER2 IQFISH Assay
February 15, 2013 / GenomeWeb Daily News
Ventana's Growing Companion Dx Focus Mirrors Parent Roche's Investment in Personalized Rx
January 18, 2012 / Pharmacogenomics Reporter
FDA Clears Dako's Companion Dx for Herceptin
December 13, 2011 / GenomeWeb Daily News